An interventional study of Goserelin Acetate in Infertility Associated With Endometriosis, sponsored by Peking University People's Hospital. Status unknown. Open to female participants aged 20 Years to 35 Years. Per ClinicalTrials.gov, last updated 2016-05-20.
Sponsored by Peking University People's Hospital · Not applicable, Interventional, and Treatment
This study is a multicenter, randomized-control-trial. This study select 1184 Infertile patients associated with endometriosis diagnosed by laparoscopy surgery. Patients are going to be divided into two groups according to 1:1 ratio randomly assigned to receive GnRH-a. Cumulative pregnancy rate, end of treatment to natural pregnancy time, accept the assisted reproductive treatment rate, miscarriage rate, live birth rate will be recorded.
925 studies on the registry are indexed under Endometriosis; 264 are open to participants now.
This study's planned enrollment of 1,184 is above the median of 65 across 539 interventional studies indexed under Endometriosis.
Browse Endometriosis studies →Peking University People's Hospital is the lead sponsor of 603 studies on the registry; 241 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
patients treated with GnRH-a after surgery and Outpatient guidance .
Drug: Goserelin Acetate
patients treated with outpatient guidance only.
Cumulative pregnancy rate
Cumulative pregnancy rate of 18 month after surgery
Time frame: 18 month after surgery
Time interval between surgery and natural pregnancy
Time interval between surgery and natural pregnancy
Time frame: 18 month after surgery
miscarriage rate
miscarriage rate of patients who get natural pregnancy
Time frame: 18 month after surgery
No study locations are listed for this record.
Plan to share: Yes — Willing to share IPD
No publications or documents are linked to this record.
This study is status unknown, as verified in May 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Goserelin
Peking University People's Hospital →